Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New organ preservation solution easier to use

02.06.2003


University of Pittsburgh researchers report results of first U.S. comparison study at the American Transplant Congress



A new organ preservation solution offers comparable results to a solution currently in widespread use but it is more cost-effective and has several logistical advantages that makes it more practical for keeping donated livers viable before being transplanted, conclude University of Pittsburgh Medical Center (UPMC) researchers who performed the first U.S. study to compare outcomes between the two solutions.

Their results comparing Histidine-Tryptophan-Ketogluterate (HTK) solution to the University of Wisconsin (UW) solution for the preservation of livers before transplantation are to be presented at the American Transplant Congress, the joint scientific meeting of the American Society of Transplant Surgeons and the American Society of Transplantation. The scientific sessions are June 1 – 4 at the Marriott Wardman Park Hotel in Washington, D.C.


Preservation solutions are used to extend the period that an organ remains viable, starting from the time it is removed from the donor to the time it is transplanted into a recipient. Each organ has its own limitations for how long this period can be extended. With current technology, hearts and lungs can be preserved safely for four to six hours while livers can be preserved for about 12 to 18 hours. Kidneys have a shelf life of about 24 hours. Preservation solutions allow organs to be transported between donor hospitals and transplant centers and serve to cool the organ as well as prevent cellular swelling and biochemical injury, processes that influence the function and survival of the organ once transplanted.

According to Bijan Eghtesad, M.D., associate professor of surgery at the University of Pittsburgh’s Thomas E. Starzl Transplantation Institute, outcome measures looking at initial organ function, the incidence of primary nonfunction and other clinical measures were similar between the two solutions when 84 liver transplants using HTK were compared to 167 transplants using UW. The two groups were matched for age of the recipient and donor and for cold ischemia time, the period of time that a donor organ is without a blood supply.

However, HTK’s much lower viscosity, which is nearly identical to water, and its biochemical makeup offer certain advantages that make it more practical and easier to use. For instance, surgeons found it to penetrate the liver’s vessels and bile duct structures better.

"While further study is needed, we believe that this lower viscosity makes it a better solution to use for livers recovered from non-heart beating donors because of its ability to flush out any residual blood left behind in vessels by the sudden stoppage of the heart," explained Dr. Eghtesad. Of the 84 liver transplants using HTK in the Pittsburgh study, eight involved non-heart beating donors.

Because HTK contains much less potassium, high levels of which can cause cardiac arrest, surgeons had fewer concerns about traces of the solution presenting such risk.

HTK does not need to be stored or transported in cold storage as does UW solution, and no additional products are required when using it. In addition, the Pittsburgh study found there to be less wastage of the product due to the solution’s packaging.

A cost-analysis done by the Center for Organ Recovery and Education, the organ procurement organization that serves UPMC, indicated that HTK is also more cost effective than UW. Based on 160 cases, the projected annual savings is between $73,000 and $137,000, reports Dr. Eghtesad.

Since February 2002, HTK has been the solution routinely used at UPMC for all liver, kidney and pancreas transplants.

HTK was developed by German company Dr. Franz Kohler Chemie GmbH, located in Alsbach-Hahnlein, and is marketed in the United States as CustodiolÒ HTK Solution by Odyssey Pharmaceuticals Inc. of East Hanover, N.J. The U.S. Food and Drug Administration has approved its use for preservation of donor kidneys. A number of European transplant centers have extensive experience with HTK but it is not widely used in the United States at this time. UW solution is marketed as ViaSpanä by Barr Laboratories of Pamona, N.Y.


CONTACT:
Lisa Rossi (Cell 412-916-3315)
Michele Baum
PHONE: 412-647-3555
FAX: 412-624-3184
E-MAIL:
RossiL@upmc.edu
BaumMD@upmc.edu

Lisa Rossi | EurekAlert!
Further information:
http://www.upmc.edu/

More articles from Health and Medicine:

nachricht Building blocks for new medications: the University of Graz is seeking a technology partner
19.03.2019 | Karl-Franzens-Universität Graz

nachricht Scientists find new approach that shows promise for treating cystic fibrosis
14.03.2019 | NIH/National Heart, Lung and Blood Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Stellar cartography

The Potsdam Echelle Polarimetric and Spectroscopic Instrument (PEPSI) at the Large Binocular Telescope (LBT) in Arizona released its first image of the surface magnetic field of another star. In a paper in the European journal Astronomy & Astrophysics, the PEPSI team presents a Zeeman- Doppler-Image of the surface of the magnetically active star II Pegasi.

A special technique allows astronomers to resolve the surfaces of faraway stars. Those are otherwise only seen as point sources, even in the largest telescopes...

Im Focus: Heading towards a tsunami of light

Researchers at Chalmers University of Technology and the University of Gothenburg, Sweden, have proposed a way to create a completely new source of radiation. Ultra-intense light pulses consist of the motion of a single wave and can be described as a tsunami of light. The strong wave can be used to study interactions between matter and light in a unique way. Their research is now published in the scientific journal Physical Review Letters.

"This source of radiation lets us look at reality through a new angle - it is like twisting a mirror and discovering something completely different," says...

Im Focus: Revealing the secret of the vacuum for the first time

New research group at the University of Jena combines theory and experiment to demonstrate for the first time certain physical processes in a quantum vacuum

For most people, a vacuum is an empty space. Quantum physics, on the other hand, assumes that even in this lowest-energy state, particles and antiparticles...

Im Focus: Sussex scientists one step closer to a clock that could replace GPS and Galileo

Physicists in the EPic Lab at University of Sussex make crucial development in global race to develop a portable atomic clock

Scientists in the Emergent Photonics Lab (EPic Lab) at the University of Sussex have made a breakthrough to a crucial element of an atomic clock - devices...

Im Focus: Sensing shakes

A new way to sense earthquakes could help improve early warning systems

Every year earthquakes worldwide claim hundreds or even thousands of lives. Forewarning allows people to head for safety and a matter of seconds could spell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

International Modelica Conference with 330 visitors from 21 countries at OTH Regensburg

11.03.2019 | Event News

Selection Completed: 580 Young Scientists from 88 Countries at the Lindau Nobel Laureate Meeting

01.03.2019 | Event News

LightMAT 2019 – 3rd International Conference on Light Materials – Science and Technology

28.02.2019 | Event News

 
Latest News

Levitating objects with light

19.03.2019 | Physics and Astronomy

New technique for in-cell distance determination

19.03.2019 | Life Sciences

Stellar cartography

19.03.2019 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>